| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358) | Aadi Bioscience, Inc. | 2022-02-15 |
| Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors (NCT05141474) | Vall d'Hebron Institute of Oncology | 2021-10-28 |
| A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors (NCT04571892) | Shanghai East Hospital | 2020-10-15 |
| A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. (NCT04116541) | Centre Leon Berard | 2020-01-28 |
| CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) (NCT04151342) | University Health Network, Toronto | 2020-01-17 |
| Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors (NCT04145622) | Daiichi Sankyo | 2019-11-03 |
| GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599) | Genmab | 2019-09-17 |
| Targeted T-cell Therapy in Solid Tumors (NCT04076137) | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. | 2019-05-01 |
| Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services (NCT03905720) | University of California, San Francisco | 2019-01-17 |
| A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies (NCT03834662) | Bristol-Myers Squibb | 2019-01-07 |
| A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. (NCT03553108) | AstraZeneca | 2018-05-16 |
| Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor (NCT03551795) | Xiaoyan Zhang | 2018-01-01 |
| A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors (NCT03192345) | Sanofi | 2017-06-09 |
| A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours (NCT03009214) | amcure GmbH | 2016-12-01 |
| RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) (NCT02801097) | EpicentRx, Inc. | 2016-08-30 |
| An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab (NCT02754141) | Bristol-Myers Squibb | 2016-06-21 |
| A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab (NCT02518958) | EpicentRx, Inc. | 2015-07-21 |
| Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers (NCT02252211) | Ludwig Institute for Cancer Research | 2014-12-09 |
| A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 (NCT02096341) | EpicentRx, Inc. | 2014-04-01 |
| EXtendedAnalysis for Cancer Treatment (NCT02999750) | Medical University of Vienna | 2013-10-01 |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain (NCT01846429) | H. Lee Moffitt Cancer Center and Research Institute | 2013-09-01 |
| A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin (NCT01606748) | Eli Lilly and Company | 2012-08-01 |
| Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors (NCT01670175) | University of California, San Francisco | 2012-08-01 |
| A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors (NCT01515306) | Eli Lilly and Company | 2012-07-19 |
| Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors (NCT01632696) | Peregrine Pharmaceuticals | 2012-06-01 |
| An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies (NCT01457118) | Nektar Therapeutics | 2011-10-01 |
| Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients (NCT01309490) | Jewish General Hospital | 2011-03-17 |
| ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan (NCT00836888) | Ono Pharmaceutical Co., Ltd. | 2009-01-01 |
| A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread (NCT01648764) | Eli Lilly and Company | 2008-09-01 |
| A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma (NCT00725634) | AVEO Pharmaceuticals, Inc. | 2008-09-01 |
| A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer (NCT00452413) | Eli Lilly and Company | 2007-05-01 |